Gujarat Themis Biosyn Ltd
Q1 FY27, unaudited
- Revenue
- ₹43.79 Cr
- Profit after tax
- ₹11.07 Cr
As filed with the exchange, consolidated basis.
Statement of profit and loss
Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.
| ₹ crore | Q1 FY27 | vs a year ago | — |
|---|---|---|---|
| Revenue from operations | 43.79 | — | — |
| Other income | 0.13 | — | — |
| Total income | 43.92 | — | — |
| Employee benefit expense | 4.72 | — | — |
| Finance costs | 1.79 | — | — |
| Depreciation & amortisation | 3.97 | — | — |
| Total expenses | 28.76 | — | — |
| Profit before tax | 15.17 | — | — |
| Tax expense | 4.10 | — | — |
| Profit after tax | 11.07 | — | — |
| Total comprehensive income | 11.07 | — | — |
| Earnings per share, basic | ₹1.02 | — |
|---|---|---|
| Earnings per share, diluted | ₹1.02 | — |
Q1 FY27 — unaudited, from the company’s filing with NSE. Source
Q1 FY27 results for every company Parakho holds
Why the dash
Parakho has not ingested this company’s year-ago quarter, so the change column stays empty. A dash means we do not hold the figure — never that it is zero.
Earnings call
Q1 FY27Gujarat Themis Biosyn reported Q1 FY27 revenue of INR43.8 crores, up 22.1% year-on-year, with EBITDA growing 49.4% to INR20.8 crores at a 47.5% margin. Management discussed two announced acquisitions, MicroBiopharm Japan and a portfolio of 13 brands from Sanofi France, describing plans to fund them through a mix of equity and debt. Management also addressed expanded fermentation capacity, the API block ramp-up, and a resolved dispute with Optimus Drugs.
Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote.
Filings
12 shown · 103 published by the exchange
12 Oct 2026
01 Oct 2026
FilingShareholder Meeting / Postal Ballot-Scrutinizer''s Report
Appears 2 times in the recent filings shown; listed once.
30 Sept 2026
30 Sept 2026
FilingShareholder Meeting / Postal Ballot-Outcome of AGM
Appears 2 times in the recent filings shown; listed once.
30 Sept 2026
23 Sept 2026
Insider trading23 Sept 2026
Filing21 Sept 2026
18 Sept 2026
18 Sept 2026
Filing16 Sept 2026
Filing10 Sept 2026
BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.
Industry
Healthcare › Pharmaceuticals
Classification as published by BSE.
Companies also in Pharmaceuticals, in alphabetical order
Page generated from filings held to 12 Oct 2026.